Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

被引：87

作者：

Body, J. -J. ^{[2
]}

Bergmann, P. ^{[3
]}

Boonen, S. ^{[4
]}

Boutsen, Y. ^{[5
]}

Devogelaer, J. -P. ^{[6
]}

Goemaere, S. ^{[7
]}

Kaufman, J. -M. ^{[8
]}

Rozenberg, S. ^{[9
]}

Reginster, J. -Y. ^{[1
,10
]}

机构：

[1] CHU Ctr Ville, Bone & Cartilage Metab Res Unit, Policlin L BRULL, B-4020 Liege, Belgium

[2] Univ Libre Bruxelles, Dept Med, CHU Brugmann, Brussels, Belgium

[3] Univ Libre Bruxelles, Dept Radioisotopes, CHU Brugmann, Brussels, Belgium

[4] Katholieke Univ Leuven, Ctr Metab Bone Dis, Louvain, Belgium

[5] Catholic Univ Louvain, Dept Rheumatol, Mont Godinne Univ Hosp, B-1200 Brussels, Belgium

[6] Catholic Univ Louvain, Dept Rheumatol, St Luc Univ Hosp, B-1200 Brussels, Belgium

[7] Univ Ghent, Dept Rheumatol & Endocrinol, B-9000 Ghent, Belgium

[8] State Univ Gent, Dept Endocrinol, Ghent, Belgium

[9] Univ Libre Bruxelles, Dept Gynaecol Obstet, Brussels, Belgium

[10] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium

来源：

OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷 / 10期

关键词：

Bisphosphonate; Osteoporosis; Raloxifene; Strontium; Teriparatide; VITAMIN-D SUPPLEMENTATION; MONTHLY ORAL IBANDRONATE; VERTEBRAL FRACTURE RISK; CONTINUING OUTCOMES RELEVANT; INTRAVENOUS ZOLEDRONIC ACID; STRONTIUM RANELATE; MINERAL DENSITY; NONVERTEBRAL FRACTURES; BREAST-CANCER; PARATHYROID-HORMONE;

D O I：

10.1007/s00198-010-1223-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.

引用

页码：1657 / 1680

页数：24

共 156 条

[31]

Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/jbmr.080901, 10.1359/JBMR.0809010]

[32] The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis [J].

Brown, JP ;

Kendler, DL ;

McClung, MR ;

Emkey, RD ;

Adachi, JD ;

Bolognese, MA ;

Li, Z ;

Balske, A ;

Lindsay, R .

CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (02) :103-111

[33] Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate [J].

Bruyere, Olivier ;

Roux, Christian ;

Detilleux, Johann ;

Slosman, Daniel O. ;

Spector, Tim D. ;

Fardellone, Patrice ;

Brixen, Kim ;

Devogelaer, Jean-Pierre ;

Diaz-Curiel, Manuel ;

Albanese, Carlina ;

Kaufman, Jean-Marc ;

Pors-Nielsen, Stig ;

Reginster, Jean-Yves .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :3076-3081

[34] The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro [J].

Canalis, E ;

Hott, M ;

Deloffre, P ;

Tsouderos, Y ;

Marie, PJ .

BONE, 1996, 18 (06) :517-523

[35] Mechanisms of anabolic therapies for osteoporosis [J].

Canalis, Ernesto ;

Giustina, Andrea ;

Bilezikian, John P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09) :905-916

[36] Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women [J].

Canonico, Marianne ;

Bouaziz, Elodie ;

Carcaillon, Laure ;

Verstuyft, Celine ;

Guiochon-Mantel, Anne ;

Becquemont, Laurent ;

Scarabin, Pierre-Yves .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (08) :3082-3087

[37] Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study [J].

Chapurlat, Roland D. ;

Arlot, Monique ;

Burt-Pichat, Brigitte ;

Chavassieux, Pascale ;

Roux, Jean Paul ;

Portero-Muzy, Nathalie ;

Delmas, Pierre D. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) :1502-1509

[38] EFFECT OF CALCIUM AND CHOLECALCIFEROL TREATMENT FOR 3 YEARS ON HIP-FRACTURES IN ELDERLY WOMEN [J].

CHAPUY, MC ;

ARLOT, ME ;

DELMAS, PD ;

MEUNIER, PJ .

BRITISH MEDICAL JOURNAL, 1994, 308 (6936) :1081-1082

[39] Combined calcium and vitamin D3 supplementation in elderly women:: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk:: The Decalyos II study [J].

Chapuy, MC ;

Pamphile, R ;

Paris, E ;

Kempf, C ;

Schlichting, M ;

Arnaud, S ;

Garnero, P ;

Meunier, PJ .

OSTEOPOROSIS INTERNATIONAL, 2002, 13 (03) :257-264

[40] VITAMIN-D(3) AND CALCIUM TO PREVENT HIP-FRACTURES IN ELDERLY WOMEN [J].

CHAPUY, MC ;

ARLOT, ME ;

DUBOEUF, F ;

BRUN, J ;

CROUZET, B ;

ARNAUD, S ;

DELMAS, PD ;

MEUNIER, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) :1637-1642

← 1 2 3 4 5 6 7 8 9 10 →